Showing results (101-110 of 676) with videos related to
Sort By:
Pageof 68
Clinical Advances in Hematology & Oncology : H&O|December 2, 2006
Managing patients with low-risk MDSMikkael Sekeres, Denise Cosgrove, Angela FalcoClinical Advances in Hematology & Oncology : H&O|December 2, 2006
The role of targeted therapy in the treatment of colorectal cancerRichard M Goldberg, Herbert I Hurwitz, Charles S FuchsClinical Advances in Hematology & Oncology : H&O|December 2, 2006
The role of angiogenesis inhibition in the treatment of breast cancerGeorge W Sledge, Hope S Rugo, Harold J BursteinClinical Advances in Hematology & Oncology : H&O|December 7, 2006
Clinical proteomics: the promises and challenges of mass spectrometry-based biomarker discoveryImelda E deVera, Jonathan E Katz, David B AgusClinical Advances in Hematology & Oncology : H&O|December 5, 2006
Novel targets in solid tumors: MEK inhibitorsWells A Messersmith, Manuel Hidalgo, Michael Carducci, et al.Clinical Advances in Hematology & Oncology : H&O|June 17, 2010
Multimodality therapy: bone-targeted radioisotope therapy of prostate cancerShi-Ming Tu, Sue-Hwa Lin, Donald A Podoloff, et al.Clinical Advances in Hematology & Oncology : H&O|May 28, 2010
Daptomycin use in patients with cancer and neutropenia: data from a retrospective registryKenneth V I Rolston, Scott A McConnell, Jack Brown, et al.Clinical Advances in Hematology & Oncology : H&O|August 25, 2010
FLT3 inhibitors for the treatment of acute myeloid leukemiaPeter H WiernikClinical Advances in Hematology & Oncology : H&O|June 24, 2008
Neuropathy associated with microtubule inhibitors: diagnosis, incidence, and managementSandra M Swain, Joseph C ArezzoClinical Advances in Hematology & Oncology : H&O|April 20, 2010
Renal cell carcinoma therapy in 2010: many options with little comparative dataSumanta Kumar Pal, Robert A FiglinPageof 68